Two Sigma Securities’s Whitehawk Therapeutics WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46K Buy
+10,033
New +$41.7K ﹤0.01% 1395
2025
Q3
Sell
-11,103
Closed -$20.8K 2140
2025
Q2
$20.8K Buy
+11,103
New +$19.3K ﹤0.01% 1203
2020
Q3
Sell
-1,645
Closed -$31K 1713
2020
Q2
$31K Buy
+1,645
New +$21.5K ﹤0.01% 1277
2019
Q2
Sell
-800
Closed -$11K 2493
2019
Q1
$11K Buy
+800
New +$34.4K ﹤0.01% 1727

Other funds holding WHWK

Two Sigma Securities's WHWK Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 10,033 shares worth $46K. The stake represents ﹤0.01% of the portfolio and ranks #1395 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in WHWK as recently as Q2 2025.

Two Sigma Securities first reported a position in WHWK in Q1 2019 and has held it in 4 quarters since. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Two Sigma Securities held 10,033 shares of Whitehawk Therapeutics worth $46K as of Q2 2026.
  • Whitehawk Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1395 holding.
  • Two Sigma Securities first reported a position in Whitehawk Therapeutics in Q1 2019 and has held it in 4 quarters since.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.